BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26281353)

  • 1. [Multifunctionality of MDM2 protein and its role in genomic instability of cancer cells].
    Małuszek M
    Postepy Biochem; 2015; 61(1):42-51. PubMed ID: 26281353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm2 affects genome stability independent of p53.
    Bouska A; Eischen CM
    Cancer Res; 2009 Mar; 69(5):1697-701. PubMed ID: 19244108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of MDM2 in Promoting Genome Stability versus Instability.
    Saadatzadeh MR; Elmi AN; Pandya PH; Bijangi-Vishehsaraei K; Ding J; Stamatkin CW; Cohen-Gadol AA; Pollok KE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
    Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2- an indispensable player in tumorigenesis.
    Zafar A; Khan MJ; Naeem A
    Mol Biol Rep; 2023 Aug; 50(8):6871-6883. PubMed ID: 37314603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine double minute 2: p53-independent roads lead to genome instability or death.
    Bouska A; Eischen CM
    Trends Biochem Sci; 2009 Jun; 34(6):279-86. PubMed ID: 19447627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
    Li M; Zhang Z; Hill DL; Wang H; Zhang R
    Cancer Res; 2007 Mar; 67(5):1988-96. PubMed ID: 17332326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
    FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-independent functions of MDM2.
    Ganguli G; Wasylyk B
    Mol Cancer Res; 2003 Dec; 1(14):1027-35. PubMed ID: 14707286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
    Bond GL; Hu W; Bond EE; Robins H; Lutzker SG; Arva NC; Bargonetti J; Bartel F; Taubert H; Wuerl P; Onel K; Yip L; Hwang SJ; Strong LC; Lozano G; Levine AJ
    Cell; 2004 Nov; 119(5):591-602. PubMed ID: 15550242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
    Freedman DA; Levine AJ
    Cancer Res; 1999 Jan; 59(1):1-7. PubMed ID: 9892174
    [No Abstract]   [Full Text] [Related]  

  • 16. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
    Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C
    Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of p53 in limiting somatic cell reprogramming.
    Liu Y; Hoya-Arias R; Nimer SD
    Cell Res; 2009 Nov; 19(11):1227-8. PubMed ID: 19881523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.